Immutep

+$0.04 (+1.13%) As of 2:06 PM UTC today

Why Robinhood?

You can buy or sell Immutep and other stocks, options, and ETFs commission-free!

About IMMP

Immutep Limited American Depositary Shares, also called Immutep, is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma.

CEO
Marc Voigt
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1987

IMMP Key Statistics

Market Cap
256.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
555.33K
High Today
$3.64
Low Today
$3.56
Open Price
$3.59
Volume
56.81K
52 Week High
$7.95
52 Week Low
$0.96

IMMP Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 28, Pre-Market

You May Also Like

BCRX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure